94 related articles for article (PubMed ID: 7492983)
1. Role of angiotensin II in the transforming growth factor-beta 1 expression of rat kidney in anti-glomerular basement membrane antiserum-induced glomerulonephritis.
Yayama K; Makino J; Takano M; Okamoto H
Biol Pharm Bull; 1995 May; 18(5):687-90. PubMed ID: 7492983
[TBL] [Abstract][Full Text] [Related]
2. Activation of the renin-angiotensin system in anti-glomerular basement membrane antibody-induced glomerulonephritis.
Yayama K; Matsui T; Takano M; Hayashi K; Nagamatsu T; Suzuki Y; Okamoto H
Biol Pharm Bull; 1995 Mar; 18(3):411-5. PubMed ID: 7550093
[TBL] [Abstract][Full Text] [Related]
3. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
[TBL] [Abstract][Full Text] [Related]
4. Distinct contribution of Fc receptors and angiotensin II-dependent pathways in anti-GBM glomerulonephritis.
Suzuki Y; Shirato I; Okumura K; Ravetch JV; Takai T; Tomino Y; Ra C
Kidney Int; 1998 Oct; 54(4):1166-74. PubMed ID: 9767532
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
[TBL] [Abstract][Full Text] [Related]
6. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery.
Kim S; Kawamura M; Wanibuchi H; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Iwao H
Circulation; 1995 Jul; 92(1):88-95. PubMed ID: 7788922
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta 1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system.
Omura T; Kim S; Takeuchi K; Iwao H; Takeda T
Cardiovasc Res; 1994 Dec; 28(12):1835-42. PubMed ID: 7867037
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats.
Otsuka F; Yamauchi T; Kataoka H; Mimura Y; Ogura T; Makino H
Am J Physiol; 1998 Jun; 274(6):R1797-806. PubMed ID: 9841488
[TBL] [Abstract][Full Text] [Related]
10. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis.
Wenzel UO; Thaiss F; Helmchen U; Stahl RA; Wolf G
Kidney Int; 2002 Mar; 61(3):1020-9. PubMed ID: 11849457
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
13. Immunoelectron microscopic study on type I, II and III TGF-beta receptors on visceral glomerular epithelial cells in relation to glomerular basement membrane alterations in proteinuric rats.
Fujigaki Y; Watanabe T; Ikegaya N; Yonemura K; Sun DF; Hishida A; Yamamoto T; Kojima K; Nagase M
Nephrol Dial Transplant; 2000 Feb; 15(2):191-9. PubMed ID: 10648664
[TBL] [Abstract][Full Text] [Related]
14. Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction.
Chung KH; Gomez RA; Chevalier RL
Am J Physiol; 1995 Jun; 268(6 Pt 2):F1117-23. PubMed ID: 7611452
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II inhibits interleukin-1 beta-induced nitric oxide production in cultured rat mesangial cells.
Kihara M; Yabana M; Toya Y; Kobayashi S; Fujita T; Iwamoto T; Ishigami T; Umemura S
Kidney Int; 1999 Apr; 55(4):1277-83. PubMed ID: 10200991
[TBL] [Abstract][Full Text] [Related]
16. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
17. Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.
Urushihara M; Ohashi N; Miyata K; Satou R; Acres OW; Kobori H
Hypertension; 2011 Mar; 57(3):586-93. PubMed ID: 21282555
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis.
Nagamatsu T; Hayashi K; Oka T; Suzuki Y
Eur J Pharmacol; 1999 Jun; 374(1):93-101. PubMed ID: 10422645
[TBL] [Abstract][Full Text] [Related]
19. Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis.
Morath C; Dechow C; Lehrke I; Haxsen V; Waldherr R; Floege J; Ritz E; Wagner J
J Am Soc Nephrol; 2001 Nov; 12(11):2300-2309. PubMed ID: 11675406
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of extracellular matrix and its regulatory proteins during the process of interstitial fibrosis after anti-glomerular basement membrane antibody-induced glomerular sclerosis in Sprague-Dawley rats.
Adhikary LP; Yamamoto T; Isome M; Nakano Y; Kawasaki K; Yaoita E; Kihara I
Pathol Int; 1999 Aug; 49(8):716-25. PubMed ID: 10504539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
